| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| R&D Expense | $129K | +68.5% |
| SG&A Expense | $815K | +46.7% |
| Operating Income | -$1.1M | -37.9% |
| Interest Expense | $71K | +18.9% |
| Net Income | -$1.7M | -78.7% |
| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $127K | +1128.0% |
| Current Assets | $141K | +816.9% |
| Total Assets | $176K | +248.8% |
| Current Liabilities | $2.4M | +3.7% |
| Stockholders' Equity | -$2.3M | +6.3% |
| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.0M | -83.7% |
| Financing Cash Flow | $1.2M | +128.9% |